1. Home
  2. FSI vs QNCX Comparison

FSI vs QNCX Comparison

Compare FSI & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSI
  • QNCX
  • Stock Information
  • Founded
  • FSI 1991
  • QNCX 2012
  • Country
  • FSI Canada
  • QNCX United States
  • Employees
  • FSI N/A
  • QNCX N/A
  • Industry
  • FSI Recreational Games/Products/Toys
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FSI Consumer Discretionary
  • QNCX Health Care
  • Exchange
  • FSI Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • FSI 120.2M
  • QNCX 100.4M
  • IPO Year
  • FSI 1999
  • QNCX 2019
  • Fundamental
  • Price
  • FSI $9.47
  • QNCX $1.77
  • Analyst Decision
  • FSI
  • QNCX Strong Buy
  • Analyst Count
  • FSI 0
  • QNCX 6
  • Target Price
  • FSI N/A
  • QNCX $8.00
  • AVG Volume (30 Days)
  • FSI 61.0K
  • QNCX 433.6K
  • Earning Date
  • FSI 11-14-2025
  • QNCX 11-12-2025
  • Dividend Yield
  • FSI 1.03%
  • QNCX N/A
  • EPS Growth
  • FSI 5.17
  • QNCX N/A
  • EPS
  • FSI 0.23
  • QNCX N/A
  • Revenue
  • FSI $37,322,073.00
  • QNCX N/A
  • Revenue This Year
  • FSI $11.26
  • QNCX N/A
  • Revenue Next Year
  • FSI $52.79
  • QNCX N/A
  • P/E Ratio
  • FSI $41.95
  • QNCX N/A
  • Revenue Growth
  • FSI N/A
  • QNCX N/A
  • 52 Week Low
  • FSI $3.46
  • QNCX $0.72
  • 52 Week High
  • FSI $11.48
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • FSI 55.33
  • QNCX 49.65
  • Support Level
  • FSI $8.34
  • QNCX $1.76
  • Resistance Level
  • FSI $9.36
  • QNCX $1.95
  • Average True Range (ATR)
  • FSI 0.62
  • QNCX 0.17
  • MACD
  • FSI -0.01
  • QNCX -0.02
  • Stochastic Oscillator
  • FSI 85.52
  • QNCX 27.62

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: